These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34717048)

  • 1. The negative impact of T cell-mediated rejection on renal allograft survival in the modern era.
    Rampersad C; Balshaw R; Gibson IW; Ho J; Shaw J; Karpinski M; Goldberg A; Birk P; Rush DN; Nickerson PW; Wiebe C
    Am J Transplant; 2022 Mar; 22(3):761-771. PubMed ID: 34717048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejection.
    Wiebe C; Rush DN; Gibson IW; Pochinco D; Birk PE; Goldberg A; Blydt-Hansen T; Karpinski M; Shaw J; Ho J; Nickerson PW
    Am J Transplant; 2020 Sep; 20(9):2499-2508. PubMed ID: 32185878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.
    Wiebe C; Kosmoliaptsis V; Pochinco D; Gibson IW; Ho J; Birk PE; Goldberg A; Karpinski M; Shaw J; Rush DN; Nickerson PW
    Am J Transplant; 2019 Jun; 19(6):1708-1719. PubMed ID: 30414349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell Mediated Rejection Associated Microvascular Inflammation in the Allograft Kidney: RNAseq Analysis Using the Banff Human Organ Transplant Gene Panel.
    Barwad A; Huang Y; Randhawa P
    Clin Transplant; 2024 Jul; 38(7):e15410. PubMed ID: 39033507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.
    Bouatou Y; Viglietti D; Pievani D; Louis K; Duong Van Huyen JP; Rabant M; Aubert O; Taupin JL; Glotz D; Legendre C; Loupy A; Lefaucheur C
    Am J Transplant; 2019 Jul; 19(7):1972-1988. PubMed ID: 30748089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.
    Lefaucheur C; Gosset C; Rabant M; Viglietti D; Verine J; Aubert O; Louis K; Glotz D; Legendre C; Duong Van Huyen JP; Loupy A
    Am J Transplant; 2018 Feb; 18(2):377-390. PubMed ID: 29086461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: An analysis of indication and follow-up biopsies.
    Spitznagel T; Matter LS; Kaufmann YL; Nilsson J; von Moos S; Schachtner T
    Front Immunol; 2022; 13():949933. PubMed ID: 36059499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the Etiology of Renal Allograft Dysfunction Using Banff 2019 Classification: Correlation with Post-Transplant Duration and Creatinine Levels-A Comprehensive Analysis of 200 Renal Biopsies at a Tertiary Care Medical Center Hospital.
    Saleem R; Nasir H; Chakravarty T; Mansoor I; Alazawi S; Ballouk C; Abdulwaasey M; Shaker N; Sangueza OP; Shaker N
    Int J Surg Pathol; 2024 Oct; ():10668969241283737. PubMed ID: 39360394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early allograft inflammation and scarring associate with graft dysfunction and poor outcomes in renal transplant recipients with delayed graft function: a prospective single center cohort study.
    Cherukuri A; Mehta R; Sood P; Hariharan S
    Transpl Int; 2018 Dec; 31(12):1369-1379. PubMed ID: 30007072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Pathologic Features and Graft Outcomes of Rejection on Kidney Transplant.
    Park WY; Paek JH; Jin K; Park SB; Choe M; Han S
    Transplant Proc; 2019 Oct; 51(8):2655-2659. PubMed ID: 31345597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?
    Nankivell BJ; P'Ng CH; Chapman JR
    Am J Transplant; 2019 Jan; 19(1):132-144. PubMed ID: 29687946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic changes in blood routine and peripheral blood lymphocyte subpopulations in recipients of different types of rejection.
    Luo S; Nie M; Song L; Xie Y; Zhong M; Tan S; An R; Li P; Tan L; Xie X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):417-425. PubMed ID: 38970516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
    Wehmeier C; Hönger G; Cun H; Amico P; Hirt-Minkowski P; Georgalis A; Hopfer H; Dickenmann M; Steiger J; Schaub S
    Am J Transplant; 2017 Aug; 17(8):2092-2102. PubMed ID: 28245084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.